PURE Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
PURE Bioscience, Inc. (PURE) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 1.51 million shares as of 2020-07-31, per its 10-K filed 2020-10-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2020-10-08
- 2020-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.51M shares.
- 2020-04-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.51M shares.
- 2020-01-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.51M shares.
- 2019-10-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.51M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2020-07-31 | 1.51M shares 10-K · filed 2020-10-08 |
| 2020-04-30 | 1.51M shares 10-Q · filed 2020-06-11 |
| 2020-01-31 | 1.51M shares 10-Q · filed 2020-03-12 |
| 2019-10-31 | 1.51M shares 10-Q · filed 2019-12-13 |
| 2019-07-31 | 1.91M shares 10-Q · filed 2020-06-11 |
| 2018-07-31 | 1.52M shares 10-K · filed 2019-10-30 |
| 2017-07-31 | 2.04M shares 10-K · filed 2019-10-30 |
| 2015-07-31 | 3.21M shares 10-K · filed 2015-10-28 |
| 2014-07-31 | 4.83M shares 10-K · filed 2015-10-28 |